Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1050 of 1958 entries
View as:

A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03942042 Org: User:
Start: 07/05/19 End: 07/22/20 Due: 07/22/21

A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)

Phase: N/A Priority: Normal
NCT ID: NCT01191268 Org: User:
Start: 11/30/10 End: 09/30/12 Due: 09/30/13

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Phase: N/A Priority: Normal
NCT ID: NCT03367390 Org: User:
Start: 11/08/17 End: 02/09/18 Due: 02/09/19

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06945419 Org: User:
Start: 04/23/25 End: 04/30/26 Due: 04/30/27

A Study for Adults With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01018810 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03131687 Org: User:
Start: 05/24/17 End: 08/01/18 Due: 08/01/19

Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00190749 Org: User:
Start: 10/31/03 End: 06/30/08 Due: 06/30/09

A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05338489 Org: User:
Start: 05/11/18 End: 08/22/18 Due: 08/22/19

Study to Compare 2 Formulations of LY900014 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03616977 Org: User:
Start: 08/03/18 End: 10/19/18 Due: 10/19/19

A Study of LY3478045 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04270370 Org: User:
Start: 03/16/20 End: 06/23/21 Due: 06/23/22

EVA: Evista Alendronate Comparison

Phase: N/A Priority: Normal
NCT ID: NCT00035971 Org: User:
Start: - End: - Due: -

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

Phase: N/A Priority: Normal
NCT ID: NCT00485498 Org: User:
Start: 04/30/03 End: 12/31/03 Due: 12/31/04

Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00529789 Org: User:
Start: 08/31/07 End: 09/30/08 Due: 09/30/09

A Study in Adults With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01421147 Org: User:
Start: 08/31/11 End: 04/30/13 Due: 04/30/14

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03086369 Org: User:
Start: 06/22/17 End: 06/17/21 Due: 06/17/22

A Study of Multiple Doses of LY2922470 in Participants With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01867216 Org: User:
Start: 06/30/13 End: 01/31/14 Due: 01/31/15

Olanzapine in Patients With Borderline Personality Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00091650 Org: User:
Start: 03/31/04 End: 11/30/05 Due: 11/30/06

Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00044863 Org: User:
Start: 08/31/02 End: 12/31/05 Due: 12/31/06

A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03482011 Org: User:
Start: 04/24/18 End: 01/16/20 Due: 01/16/21

A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01000480 Org: User:
Start: 10/31/09 End: 07/31/13 Due: 07/31/14

A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02860780 Org: User:
Start: 08/10/16 End: 05/15/17 Due: 05/15/18

A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00320541 Org: User:
Start: 05/31/06 End: 08/31/12 Due: 08/31/13

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04145349 Org: User:
Start: 01/22/20 End: 10/31/25 Due: 10/31/26

Efficacy and Safety of Duloxetine

Phase: N/A Priority: Normal
NCT ID: NCT00190619 Org: User:
Start: 05/31/01 End: 05/31/06 Due: 05/31/07

A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01316263 Org: User:
Start: 08/31/11 End: 11/30/12 Due: 11/30/13